U.S. Consumer Services Stock News

NasdaqCM:FRAF 1 Year Share Price vs Fair Value Explore Franklin Financial Services's Fair Values from the Community and...

NasdaqGS:LNW 1 Year Share Price vs Fair Value Explore Light & Wonder's Fair Values from the Community and select yours...

NasdaqGM:TCRX 1 Year Share Price vs Fair Value Explore TScan Therapeutics's Fair Values from the Community and select...

NasdaqGM:FINW 1 Year Share Price vs Fair Value Explore FinWise Bancorp's Fair Values from the Community and select...

Horizon Bancorp ( NASDAQ:HBNC ) Second Quarter 2025 Results Key Financial Results Revenue: US$63.8m (up 20% from 2Q...

NasdaqGM:TBPH 1 Year Share Price vs Fair Value Explore Theravance Biopharma's Fair Values from the Community and select...

NasdaqGS:EDIT 1 Year Share Price vs Fair Value Explore Editas Medicine's Fair Values from the Community and select...

TriCo Bancshares ( NASDAQ:TCBK ) Second Quarter 2025 Results Key Financial Results Revenue: US$98.9m (up 1.5% from 2Q...

Atlantic American ( NASDAQ:AAME ) Second Quarter 2025 Results Key Financial Results Revenue: US$55.3m (up 16% from 2Q...

NasdaqGM:RGCO 1 Year Share Price vs Fair Value Explore RGC Resources's Fair Values from the Community and select yours...

After the July Consumer Price Index report showed annual inflation holding steady at 2.7% and the National Federation of Independent Business Small Business Optimism Index rose to a five-month high, hopes strengthened for a Federal Reserve interest rate cut. This combination of stable inflation and improved small business sentiment provided a boost to confidence and activity in sectors such as IT services, manufacturing, and staffing. With the prospect of reduced interest rates supporting...

Alexandria Real Estate Equities recently announced its largest-ever lease agreement, securing a 466,000 square foot deal and reporting positive second quarter 2025 results with 2.0% cash same-property NOI growth and a 90.8% North American occupancy rate. This historic lease not only marks a key operational milestone for the life science REIT but also highlights its success in attracting major tenants amid changing industry demand. We'll consider how signing the company's largest lease may...

In recent days, the board of the Independent Development Trust (IDT) announced it is prioritizing transparency and accountability amid ongoing investigations into governance and unfinished social infrastructure projects, including a halted R173 million boarding school in the Northern Cape. The board’s active response to public and regulatory scrutiny underscores mounting external pressure to safeguard public funds and restore credibility during this period of review. We’ll examine how...

CSG Systems International recently reported its second-quarter 2025 earnings, showing revenue of US$297.13 million and confirming its full-year guidance with expected revenue between US$1.21 billion and US$1.25 billion. Steady contributions from Europe, the Middle East, Africa, and Asia-Pacific helped support the company’s stable financial outlook despite profit declines compared to the previous year. We’ll examine how confirmed full-year guidance and continued international revenue strength...

Mondelez International recently disclosed that CEO Dirk Van de Put and CFO Luca Zaramella will join a fireside chat at the Barclays Global Consumer Staples Conference on September 3, 2025, and announced new rounds of price increases to manage intense cocoa cost inflation in North America and emerging markets. This announcement highlights Mondelez's reliance on pricing power to offset rapidly rising input costs, as well as management’s focus on transparent investor engagement. We'll explore...

Vaxcyte reported its second quarter and half-year 2025 financials, recording a net loss of US$166.57 million and US$307.29 million, respectively, both wider than the same periods last year. This marks a continued trend of increasing basic loss per share from continuing operations, which reached US$1.22 in Q2 and US$2.26 for the first half of 2025. We'll explore how rising net losses add complexity to Vaxcyte’s investment narrative, especially as the company’s development costs remain in...

Lennox International Inc. recently reported second quarter results that showed both revenue growth and a 14.5% increase in adjusted earnings per share compared to the prior year. This marks the fourth consecutive quarter that Lennox International has surpassed consensus earnings estimates, signaling a period of consistently strong financial performance. We’ll now explore how Lennox’s consistent earnings outperformance may influence the company’s future outlook and investment narrative. We've...

Following the release of the July Consumer Price Index (CPI) report last week, which showed annual inflation steady at 2.7% and matched expectations, market confidence grew as the likelihood of a Federal Reserve interest rate cut jumped above 94%. Additional momentum was fueled by the National Federation of Independent Business (NFIB) Small Business Optimism Index reaching a five-month high, driving increased optimism and gains across IT services, staffing, and manufacturing sectors. With...

First Hawaiian reported steady second-quarter growth driven by higher net interest margins, strong expense management, and lower provision expenses, with CEO Bob Harrison noting broad-based business improvements and the impact of a favorable California tax law change. This tax benefit supported results without distorting underlying trends, while management indicated a continued priority toward organic expansion, dividends, and share repurchases alongside a cautious approach to potential...

Invitation Homes Inc. recently announced that its operating partnership has priced a public offering of US$600 million in 4.950% Senior Notes due 2033, with the notes fully and unconditionally guaranteed by the company and its subsidiaries. Investor interest has heightened, as options market activity suggests expectations of significant movement in Invitation Homes shares around the time of the bond offering. We'll explore how the new US$600 million senior notes issuance could impact...

Integra LifeSciences Holdings recently reported second-quarter results showing relatively flat sales at US$415.61 million, alongside a very large net loss of US$484.07 million, and updated its revenue guidance for both the third quarter and full year 2025. This combination of a significant swing to net loss, despite expectations for moderate revenue growth ahead, highlights ongoing operational and financial challenges for the company in a competitive sector. With revenue guidance pointing to...

Assurant, Inc. recently appointed Mike Campbell as Chief Operating Officer and Ryan Lumsden as President of Global Housing, signaling a renewed organizational emphasis on operational efficiency and innovation with changes effective September 15, 2025. The company’s realignment of leadership roles is aimed at driving digital integration and seamless service delivery across its global business lines. We'll explore how Assurant's leadership appointments and operational focus could shape its...

Between March 30 and June 28, 2025, Hologic completed the repurchase of 667,618 shares for US$35.62 million, bringing total buybacks under its September 2024 program to nearly 8 million shares at a cost of US$562.74 million. The company’s outlined plans to drive a rebound in its Breast Health business, reorganize its sales force, and launch its advanced Envision gantry in 2026 highlight a focus on operational improvement and technological innovation. We'll explore how Hologic's renewed...

Revolution Medicines recently announced that the US FDA granted Breakthrough Therapy Designation to elironrasib (RMC-6291), its RAS(-ON) G12C-selective inhibitor, for certain lung cancer patients who have already tried chemotherapy and immunotherapy but not KRAS G12C inhibitors. This designation could significantly accelerate the drug’s path through clinical development and regulatory review, potentially shaping Revolution Medicines' future prospects in oncology therapeutics. Following this...